You are here

Clinical Trials: Vascular Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Thursday, October 31, 2019 - 12:00
Conditions:   Type 2 Diabetes;   Peripheral Vascular Disorder Due to Diabetes Mellitus
Interventions:   Drug: Liraglutide+standard-of-care treatment;   Other: standard-of-care treatment
Sponsor:   Second Affiliated Hospital, School of Medicine, Zhejiang University
Not yet recruiting
Posted: Friday, October 11, 2019 - 12:00
Conditions:   Stroke;   Hemiparesis
Intervention:   Device: IpsiHand Treatment
Sponsors:   Columbia University;   Neurolutions, Inc.
Not yet recruiting
Posted: Thursday, September 26, 2019 - 12:00
Condition:   Diabetic Foot Ulcer
Intervention:   Drug: Corlicyte
Sponsor:   University of Colorado, Denver
Not yet recruiting
Posted: Friday, September 20, 2019 - 12:00
Condition:   Acute Ischemic Stroke
Intervention:   Biological: UMC119-06
Sponsor:   Meridigen Biotech Co., Ltd.
Not yet recruiting
Posted: Wednesday, September 18, 2019 - 12:00
Conditions:   Infarction, Middle Cerebral Artery;   Infarction, Anterior Cerebral Artery;   Cerebral Infarction;   Stroke, Ischemic;   Acute Stroke
Interventions:   Biological: human umbilical cord mesenchymal stem cells;   Biological: Placebo;   Other: standardized treatment
Sponsor:   Shanghai East Hospital
Recruiting
Posted: Thursday, September 12, 2019 - 12:00
Condition:   Chronic Stroke
Intervention:   Drug: GXNPC1
Sponsor:   Gwo Xi Stem Cell Applied Technology Co., Ltd.
Not yet recruiting
Posted: Wednesday, August 14, 2019 - 12:00
Condition:   Acute Myocardial Infarction
Intervention:   Biological: Allogeneic umbilical cord mesenchymal stem cells
Sponsor:   Ever Supreme Bio Technology Co., Ltd.
Recruiting
Posted: Friday, August 9, 2019 - 12:00
Condition:   Coronary Artery Disease
Intervention:   Biological: MCRcI® stem cells
Sponsors:   Honya Medical Inc;   Chang Gung Memorial Hospital
Recruiting
Posted: Thursday, August 8, 2019 - 12:00
Condition:   Myocardial Infarction
Intervention:   Biological: MiSaver®
Sponsors:   Honya Medical Inc;   Chung Shan Medical University
Recruiting
Posted: Tuesday, August 6, 2019 - 12:00
Conditions:   Cerebral Ischemia;   Cerebral Infarction;   Stroke, Acute
Interventions:   Drug: Normal Saline along with standard treatment;   Drug: PMZ-1620 (sovateltide) along with standard treatment
Sponsor:   Pharmazz, Inc.
Not yet recruiting

Pages